Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Ocular Therapeutix (OCUL) Other Non Operating Income (2016 - 2025)

Ocular Therapeutix has reported Other Non Operating Income over the past 12 years, most recently at $1.7 million for Q4 2025.

  • Quarterly results put Other Non Operating Income at $1.7 million for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $29000.0 (up 100.13% YoY), and the annual figure for FY2025 was $29000.0, up 100.1%.
  • Other Non Operating Income for Q4 2025 was $1.7 million at Ocular Therapeutix, up from -$938000.0 in the prior quarter.
  • Over the last five years, Other Non Operating Income for OCUL hit a ceiling of $25.0 million in Q1 2021 and a floor of -$62.2 million in Q4 2021.
  • Median Other Non Operating Income over the past 5 years was $1.4 million (2023), compared with a mean of $892666.7.
  • Biggest five-year swings in Other Non Operating Income: skyrocketed 1418900.0% in 2023 and later plummeted 2794900.0% in 2024.
  • Ocular Therapeutix's Other Non Operating Income stood at -$62.2 million in 2021, then soared by 100.0% to $1000.0 in 2022, then surged by 1377600.0% to $13.8 million in 2023, then plummeted by 44.74% to $7.6 million in 2024, then plummeted by 77.08% to $1.7 million in 2025.
  • The last three reported values for Other Non Operating Income were $1.7 million (Q4 2025), -$938000.0 (Q3 2025), and -$172000.0 (Q2 2025) per Business Quant data.